Octyl 4-methoxycinnamate
Suppliers
Names
[ CAS No. ]:
5466-77-3
[ Name ]:
Octyl 4-methoxycinnamate
[Synonym ]:
Escalol 557
Eusolex 2292
Neo Heliopan AV
2-ethylhexyl (E)-3-(4-methoxyphenyl)prop-2-enoate
3-(4-METHOXYPHENYL)-2-PROPENOIC ACID 2-ETHYLHEXYL ESTER
2-Ethylhexyl (2E)-3-(4-methoxyphenyl)acrylate
octinoxate
2-Ethylhexyl trans-4-methoxycinnamate
2-Propenoic acid, 3- (4-methoxyphenyl)-, 2-ethylhexyl ester
2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethylhexyl ester, (2E)-
Octyl p-Methoxycinnamate
Uvinul MC 80
octyl methoxycinnamate
Octyl 4-methoxycinnamate
MFCD00072582
PARSOL MCX
Uvinul 3088
2-ethylhexyl (2E)-3-(4-methoxyphenyl)prop-2-enoate
2-Ethylhexyl (2E)-3-(4-methoxyphenyl)-2-propenoate
Sunscreen AV
2-Ethylhexyl p-Methoxycinnamate
EINECS 226-775-7
Octyl Methoxyl Cinnamate
Chemical & Physical Properties
[ Density]:
1.0±0.1 g/cm3
[ Boiling Point ]:
405.3±20.0 °C at 760 mmHg
[ Molecular Formula ]:
C18H26O3
[ Molecular Weight ]:
290.397
[ Flash Point ]:
171.6±16.4 °C
[ Exact Mass ]:
290.188202
[ PSA ]:
35.53000
[ LogP ]:
5.66
[ Vapour Pressure ]:
0.0±0.9 mmHg at 25°C
[ Index of Refraction ]:
1.515
[ Storage condition ]:
2-8°C
[ Stability ]:
Stable. Incompatible with strong oxidizing agents.
[ Water Solubility ]:
<0.1 g/100 mL at 27 ºC
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves
[ Hazard Codes ]:
Xi
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ RTECS ]:
UD3392732
[ HS Code ]:
2918990090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2918990090
[ Summary ]:
2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles
J. Sci. Ind. Res. 65(10) , 808, (2006)
Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...
Chem. Res. Toxicol. 23 , 1215-22, (2010)
Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ...
Drug Metab. Dispos. 38 , 2302-8, (2010)
Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti...